Clearstead Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,741
Closed -$583K 2447
2025
Q4
$583K Buy
5,741
+2,269
+65% +$182K 0.01% 608
2025
Q3
$190K Buy
3,472
+365
+12% +$18.2K ﹤0.01% 894
2025
Q2
$165K Buy
3,107
+428
+16% +$21.7K ﹤0.01% 930
2025
Q1
$116K Buy
2,679
+254
+10% +$12.9K ﹤0.01% 953
2024
Q4
$136K Hold
2,425
﹤0.01% 947
2024
Q3
$165K Sell
2,425
-238
-9% -$13.4K ﹤0.01% 914
2024
Q2
$113K Buy
2,663
+238
+10% +$13.1K ﹤0.01% 972
2024
Q1
$135K Hold
2,425
0.01% 540
2023
Q4
$179K Sell
2,425
-2,425
-50% -$159K 0.01% 470
2023
Q3
$331K Buy
4,850
+2,425
+100% +$206K 0.01% 466
2023
Q2
$228K Hold
2,425
0.01% 412
2023
Q1
$164K Hold
2,425
0.01% 420
2022
Q4
$120K Hold
2,425
0.01% 466
2022
Q3
$79K Hold
2,425
0.01% 517
2022
Q2
$96K Hold
2,425
0.01% 508
2022
Q1
$170K Hold
2,425
0.01% 432
2021
Q4
$189K Hold
2,425
0.01% 403
2021
Q3
$231K Hold
2,425
0.02% 346
2021
Q2
$301K Hold
2,425
0.02% 293
2021
Q1
$320K Hold
2,425
0.03% 272
2020
Q4
$321K Hold
2,425
0.03% 255
2020
Q3
$247K Hold
2,425
0.03% 258
2020
Q2
$211K Hold
2,425
0.02% 261
2020
Q1
$141K Sell
2,425
-19
-0.8% -$1.54K 0.02% 282
2019
Q4
$226K Buy
2,444
+19
+0.8% +$1.67K 0.03% 262
2019
Q3
$219K Hold
2,425
0.03% 248
2019
Q2
$286K Hold
2,425
0.04% 225
2019
Q1
$210K Buy
+2,425
New +$206K 0.03% 249

Other funds holding EXAS

Clearstead Advisors's EXAS Position: Q1 2026 in Review

Clearstead Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,741 shares — an estimated $583K sold.

Clearstead Advisors first reported a position in EXAS in Q1 2019 and held it in 28 quarters. The position peaked at $583K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Clearstead Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Clearstead Advisors sold 5,741 Exact Sciences shares in Q1 2026, an estimated $583K.
  • Clearstead Advisors first reported a position in Exact Sciences in Q1 2019 and held it in 28 quarters.
  • Clearstead Advisors's Exact Sciences position peaked at $583K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.